Gerald Swiss is a retired partner and intellectual property lawyer with Foley & Lardner LLP. He concentrated his practice on strategic counseling, including implementation of IP strategy for clients in the biopharmaceutical, life science and medical device arenas. Gerald had approximately 35 years of IP experience in patent prosecution directed to protecting small molecules, chemical processes, enzymes, and medical devices. In particular, he has handled a significant amount of IP work on new chemical entity scaffolds for the treatment of cancers, anemia, thrombosis, and inflammatory diseases. He was a member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.